(Q62819148)
Statements
A Postmarketing Observational Study to Evaluate the Safety of ADASUVE® (STACCATO® Loxapine for Inhalation) in Patients With Agitation Associated With Schizophrenia or Bipolar I Disorder (English)
0 references
4 November 2014
0 references
October 2019
0 references
10,000
0 references
18 year
0 references